UBS Group’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$755K Sell
92,801
-46,546
-33% -$379K ﹤0.01% 4556
2025
Q1
$1.09M Buy
139,347
+8,283
+6% +$65K ﹤0.01% 4127
2024
Q4
$1.95M Buy
131,064
+45,168
+53% +$673K ﹤0.01% 3732
2024
Q3
$1.31M Buy
85,896
+10,783
+14% +$165K ﹤0.01% 3365
2024
Q2
$1.14M Sell
75,113
-133,616
-64% -$2.03M ﹤0.01% 3285
2024
Q1
$3.94M Buy
208,729
+46,245
+28% +$873K ﹤0.01% 2398
2023
Q4
$3.1M Buy
162,484
+104,947
+182% +$2M ﹤0.01% 2442
2023
Q3
$1.03M Sell
57,537
-41,757
-42% -$750K ﹤0.01% 3056
2023
Q2
$2.02M Buy
99,294
+637
+0.6% +$12.9K ﹤0.01% 2690
2023
Q1
$1.8M Buy
98,657
+38,909
+65% +$710K ﹤0.01% 2689
2022
Q4
$1.24M Buy
59,748
+20,052
+51% +$415K ﹤0.01% 2969
2022
Q3
$1.04M Sell
39,696
-38,382
-49% -$1M ﹤0.01% 2829
2022
Q2
$1.98M Sell
78,078
-115,801
-60% -$2.94M ﹤0.01% 2399
2022
Q1
$6.12M Buy
193,879
+188,069
+3,237% +$5.94M ﹤0.01% 1771
2021
Q4
$235K Sell
5,810
-15,146
-72% -$613K ﹤0.01% 4518
2021
Q3
$731K Buy
20,956
+13,894
+197% +$485K ﹤0.01% 3477
2021
Q2
$194K Sell
7,062
-38,352
-84% -$1.05M ﹤0.01% 4353
2021
Q1
$1.28M Buy
45,414
+45,043
+12,141% +$1.26M ﹤0.01% 3145
2020
Q4
$10K Buy
+371
New +$10K ﹤0.01% 6471
2020
Q3
Sell
-3,733
Closed -$92K 7330
2020
Q2
$92K Sell
3,733
-17,324
-82% -$427K ﹤0.01% 4545
2020
Q1
$292K Sell
21,057
-21,814
-51% -$302K ﹤0.01% 3624
2019
Q4
$433K Buy
42,871
+18,040
+73% +$182K ﹤0.01% 4006
2019
Q3
$226K Buy
24,831
+19,056
+330% +$173K ﹤0.01% 4273
2019
Q2
$46K Buy
+5,775
New +$46K ﹤0.01% 5136
2019
Q1
Sell
-13,465
Closed -$145K 7062
2018
Q4
$145K Buy
13,465
+11,187
+491% +$120K ﹤0.01% 4351
2018
Q3
$32K Buy
2,278
+1,673
+277% +$23.5K ﹤0.01% 5588
2018
Q2
$7K Buy
+605
New +$7K ﹤0.01% 6417